This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 1996 Feb;14(2):686-7.

doi: 10.1200/JCO.1996.14.2.686.

Risk stratification for high-dose chemotherapy in metastatic breast cancer

M Subar

PMID: 8636796
DOI: 10.1200/JCO.1996.14.2.686

Comment

Risk stratification for high-dose chemotherapy in metastatic breast cancer

M Subar. J Clin Oncol. 1996 Feb.

. 1996 Feb;14(2):686-7.

doi: 10.1200/JCO.1996.14.2.686.

Author

M Subar

PMID: 8636796
DOI: 10.1200/JCO.1996.14.2.686

No abstract available

PubMed Disclaimer

Comment on

High-dose chemotherapy with hematopoietic rescue as primary treatment for metastatic breast cancer: a randomized trial.
Bezwoda WR, Seymour L, Dansey RD. Bezwoda WR, et al. J Clin Oncol. 1995 Oct;13(10):2483-9. doi: 10.1200/JCO.1995.13.10.2483. J Clin Oncol. 1995. Retraction in: J Clin Oncol. 2001 Jun 1;19(11):2973. doi: 10.1200/JCO.2001.19.11.2973. PMID: 7595697 Retracted. Clinical Trial.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions

Supplementary concepts

Actions

LinkOut - more resources

Full Text Sources
- Atypon
- Ovid Technologies, Inc.
Medical
- MedlinePlus Health Information